Management of Red Man Syndrome

Prevention and Management

• The American Heart Association recommends slowing the infusion rate to at least 60 minutes and administering antihistamines prior to infusion to prevent recurrence of Red Man Syndrome 1
• To prevent recurrence in patients who require continued vancomycin therapy, extend the infusion time to at least 60-120 minutes depending on the dose, as recommended by the Infectious Diseases Society of America 1, 2
• For outpatient parenteral antimicrobial therapy (OPAT), vancomycin infusions should be administered over 60-120 minutes to minimize the risk of Red Man Syndrome, according to the Infectious Diseases Society of America 2
• Therapeutic drug monitoring should target trough vancomycin levels between 10-15 μg/mL for most infections, as suggested by the American Heart Association 1, 3

Infusion Rates and Monitoring

• Resume vancomycin at a much slower infusion rate once symptoms of Red Man Syndrome resolve, if the drug is still necessary, as recommended by the American Heart Association 1, 4

Red Man Syndrome Management

Prevention Strategies for Future Doses

• When administering loading doses of 25-30 mg/kg for seriously ill patients, prolong the infusion time to 2 hours and premedicate with an antihistamine to reduce Red Man Syndrome risk 5

Red Man Syndrome Management

Prevention Strategies for Subsequent Doses

• The Infectious Diseases Society of America recommends extending infusion time to at least 60-120 minutes for all vancomycin doses to minimize histamine release, which is the most critical preventive measure 6
• Administering vancomycin in diluted solution (at least 200 mL) can reduce concentration-dependent histamine release, according to the American Academy of Allergy, Asthma, and Immunology 7
• For loading doses of 25-30 mg/kg, prolonging infusion to 2 hours and premedicating with an antihistamine can reduce red man syndrome risk, as suggested by the Infectious Diseases Society of America 6